Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of multiple tyrosine kinase inhibitors in pediatric/adolescent and young adult patients with relapsed or refractory osteosarcomas: A single-institution retrospective analysis.
Sugiyama M, Arakawa A, Shirakawa N, Tao K, Tanimura K, Nakajima M, Watanabe Y, Kumamoto T, Maniwa J, Yoneda A, Iwata S, Kobayashi E, Kawai A, Ogawa C. Sugiyama M, et al. Among authors: kumamoto t. Pediatr Blood Cancer. 2023 Jul;70(7):e30360. doi: 10.1002/pbc.30360. Epub 2023 Apr 19. Pediatr Blood Cancer. 2023. PMID: 37073613
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project.
Tao K, Yamazaki F, Kubo T, Sunami K, Kumamoto T, Arakawa A, Sugiyama M, Watanabe Y, Nakajima M, Shirakawa N, Tanimura K, Koyama T, Hirata M, Sudo K, Tanabe N, Watanabe T, Yoshida T, Kitami M, Yoshida A, Yatabe Y, Nakano Y, Ohira M, Kamijo T, Nakazawa A, Kato M, Ichimura K, Kohno T, Yamamoto N, Hishiki T, Ichikawa H, Ogawa C. Tao K, et al. Among authors: kumamoto t. JCO Precis Oncol. 2023 Jul;7:e2200266. doi: 10.1200/PO.22.00266. JCO Precis Oncol. 2023. PMID: 37410973
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia.
Ueki H, Ogawa C, Goto H, Nishi M, Yamanaka J, Mochizuki S, Nishikawa T, Kumamoto T, Nishiuchi R, Kikuta A, Yamamoto S, Igarashi S, Sato A, Hori T, Saito AM, Watanabe T, Deguchi T, Manabe A, Horibe K, Toyoda H. Ueki H, et al. Among authors: kumamoto t. Int J Hematol. 2024 Apr;119(4):450-458. doi: 10.1007/s12185-024-03710-6. Epub 2024 Jan 25. Int J Hematol. 2024. PMID: 38267673
Monocyte/Macrophage-Specific Loss of ARNTL Suppresses Chronic Kidney Disease-Associated Cardiac Impairment.
Yoshida Y, Nishikawa N, Fukuoka K, Tsuruta A, Otsuki K, Fukuda T, Terada Y, Tanihara T, Kumamoto T, Tsukamoto R, Nishi T, Oyama K, Hamamura K, Mayanagi K, Koyanagi S, Ohdo S, Matsunaga N. Yoshida Y, et al. Among authors: kumamoto t. Int J Mol Sci. 2024 Dec 3;25(23):13009. doi: 10.3390/ijms252313009. Int J Mol Sci. 2024. PMID: 39684718 Free PMC article.
Outcomes in children with first-relapsed acute lymphoblastic leukemia in Japan: Results from JCCG Study JPLSG-ALL-R08.
Yamanaka J, Ogawa C, Arakawa A, Deguchi T, Hori T, Kiyokawa N, Ueki H, Nishi M, Mochizuki S, Nishikawa T, Kumamoto T, Nishiuchi R, Kikuta A, Yamamoto S, Koh K, Hasegawa D, Ogawa A, Watanabe K, Sato A, Saito AM, Watanabe T, Manabe A, Horibe K, Goto H, Toyoda H. Yamanaka J, et al. Among authors: kumamoto t. Pediatr Blood Cancer. 2024 Dec;71(12):e31319. doi: 10.1002/pbc.31319. Epub 2024 Sep 12. Pediatr Blood Cancer. 2024. PMID: 39267231
634 results